HK StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

TENNOR THERAP-B

254.000

+12.4005.13%

Volume:24.10K

Turnover:5.96M

Market Cap:13.29B

PE:-74.33

High:254.000

Open:242.000

Low:239.600

Close:241.600

52wk High:256.000

52wk Low:145.000

Shares:52.33M

HK Float Shares:52.33M

Volume Ratio:4.65

T/O Rate:0.05%

Dividend:- -

Dividend Rate:- -

EPS(LYR):-3.417

ROE:--

ROA:-41.38%

PB:74.62

PE(LYR):-74.33

PS:- -

Loading ...

Overview Company News Filings

Company Profile

Company Name:

TENNOR THERAP-B

Exchange:

SEHK

Establishment Date:

2012

Employees:

- -

Office Location:

218 Xinghu Street,BioBay,Unit 701,Block B7,Suzhou Industrial Park,Suzhou Area of China (Jiangsu), Pilot Fr,Suzhou,Jiangsu Province,China

Website:

http://www.tennortherapeutics.com

Zip Code:

- -

Phone:

86 512 8686 1990

Fax:

- -

Introduction:

Tennor Therapeutics (Suzhou) Ltd is a China-based company primarily engaged in the discovery and development of innovative drug products. The Company focuses on the fields of bacterial infections and bacterial metabolism diseases. The Company's products include Rifasutenizol (TNP-2198), a novel molecular entity candidate for the treatment of Helicobacter pylori, Rifaquizinone (TNP-2092) injection, a triple-targeting antibacterial drug candidate for the treatment of implant-associated bacterial infections and TNP-2092 oral, multi-targeting antibacterial drug candidate for the treatment of diseases associated with gut bacterial metabolism.

Directors

Name

Position

MA Zhen Kun

Chairman of the Board,Executive Director,Chairman of the Nomination Committee

LI Wei Gang

Independent Director,Chairman of the Audit Committee

NI Lin

Independent Director,Member of the Remuneration and Assessment Committee,Member of the Nomination Committee

LI Le Ping

Independent Director,Chairman of the Remuneration and Assessment Committee,Member of the Nomination Committee,Member of the Audit Committee

SONG Gao Guang

Director,Member of the Remuneration and Assessment Committee,Member of the Audit Committee

Shareholders

Name

Position

MA Zhen Kun

CEO,General Manager

CHEN Rong Ping

Board Secretary,Corporate Secretary,Other Senior Executives

XIE Jia Hong

Corporate Secretary

BI Jie

Chief Business Officer

GENG Guo Zhu

Other Senior Executives

CHEN Jing

Other Senior Executives

SHU Yin Jiao

Other Senior Executives

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www-web.itiger.com/stock/06872/company"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"06872","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06872\",,,,,undefined,":{"symbol":"06872","market":"HK","secType":"STK","nameCN":"TENNOR THERAP-B","latestPrice":254,"timestamp":1781229041835,"preClose":241.6,"halted":0,"volume":24100,"delay":0,"changeRate":0.051324503311258304,"floatShares":52328926,"shares":52328926,"eps":-3.417,"marketStatus":"Trading","change":12.4,"latestTime":"06-12 09:50:51","open":242,"high":254,"low":239.6,"amount":5964710,"amplitude":0.059603,"askPrice":254.2,"askSize":500,"bidPrice":253.4,"bidSize":100,"shortable":0,"etf":0,"ttmEps":-3.242,"tradingStatus":2,"nextMarketStatus":{"tag":"Noon Closed","tradingStatus":4,"beginTime":1781236800000},"marketStatusCode":2,"adr":0,"listingDate":1779379200000,"exchange":"SEHK","adjPreClose":241.6,"openAndCloseTimeList":[[1781227800000,1781236800000],[1781240400000,1781251200000]],"volumeRatio":4.653539,"lotSize":50,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06872\",,,,,undefined,":{"symbol":"06872","floatShares":52328926,"roa":"-41.38%","roe":"--","lyrEps":-3.417,"volumeRatio":4.653539,"shares":52328926,"dividePrice":0,"high":254,"amplitude":0.059603,"preClose":241.6,"low":239.6,"week52Low":145,"pbRate":"74.62","week52High":256,"institutionHeld":0,"latestPrice":254,"committee":-0.666667,"eps":-3.417,"divideRate":0,"volume":24100,"delay":0,"ttmEps":-3.242,"open":242,"prevYearClose":75.7,"prevWeekClose":215.4,"prevMonthClose":203.6,"prevQuarterClose":75.7,"fiveDayClose":215.4,"twentyDayClose":75.7,"sixtyDayClose":75.7},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/06872\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"06872\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"06872\",market:\"HK\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/06872\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"06872","date":"2026-06-11","current":-74.58359,"percent":0,"low":-70.544358,"twenty":-63.711632,"median":-61.483388,"eighty":-59.375338,"high":-22.197537,"avg":-59.719054,"sd":10.697879,"marketCap":12503639801},"quantilePoints":[{"date":"2026-05-22","current":-61.8716,"twenty":-53.936788,"median":-42.034569,"eighty":-30.13235,"marketCap":10919983436},{"date":"2026-05-29","current":-59.494815,"twenty":-62.838158,"median":-61.618293,"eighty":-59.494815,"marketCap":10537007713},{"date":"2026-06-05","current":-62.851725,"twenty":-62.838158,"median":-60.050534,"eighty":-58.89743,"marketCap":11147698730},{"date":"2026-06-11","current":-70.544358,"twenty":-63.711632,"median":-61.483388,"eighty":-59.375338,"marketCap":12503639801}],"updateTime":1781227958392},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":254161949,"yearFounded":2012,"address":"218 Xinghu Street,BioBay,Unit 701,Block B7,Suzhou Industrial Park,Suzhou Area of China (Jiangsu), Pilot Fr,Suzhou,Jiangsu Province,China","officePhone":"86 512 8686 1990","fiscalYearEnd":"12-31"},"stockCompanyDetail":{"websiteUrl":"http://www.tennortherapeutics.com","stockEarnings":[{"period":"1week","weight":0.1252},{"period":"1month","weight":2.0383},{"period":"ytd","weight":2.0383}],"compareEarnings":[{"period":"1week","weight":-0.0478},{"period":"1month","weight":-0.0757},{"period":"3month","weight":-0.0509},{"period":"6month","weight":-0.0604},{"period":"1year","weight":0.0101},{"period":"ytd","weight":-0.0477}],"compareStock":{"symbol":"HSI","name":"HSI"},"description":"Tennor Therapeutics (Suzhou) Ltd is a China-based company primarily engaged in the discovery and development of innovative drug products. The Company focuses on the fields of bacterial infections and bacterial metabolism diseases. The Company's products include Rifasutenizol (TNP-2198), a novel molecular entity candidate for the treatment of Helicobacter pylori, Rifaquizinone (TNP-2092) injection, a triple-targeting antibacterial drug candidate for the treatment of implant-associated bacterial infections and TNP-2092 oral, multi-targeting antibacterial drug candidate for the treatment of diseases associated with gut bacterial metabolism.","exchange":"SEHK","name":"TENNOR THERAP-B","nameEN":"TENNOR THERAP-B"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"06872\",market:\"HK\",,,undefined,":{"directors":[{"name":"MA Zhen Kun","position":"Chairman of the Board,Executive Director,Chairman of the Nomination Committee"},{"name":"LI Wei Gang","position":"Independent Director,Chairman of the Audit Committee"},{"name":"NI Lin","position":"Independent Director,Member of the Remuneration and Assessment Committee,Member of the Nomination Committee"},{"name":"LI Le Ping","position":"Independent Director,Chairman of the Remuneration and Assessment Committee,Member of the Nomination Committee,Member of the Audit Committee"},{"name":"SONG Gao Guang","position":"Director,Member of the Remuneration and Assessment Committee,Member of the Audit Committee"}],"executives":[{"name":"MA Zhen Kun","position":"CEO,General Manager"},{"name":"CHEN Rong Ping","position":"Board Secretary,Corporate Secretary,Other Senior Executives"},{"name":"XIE Jia Hong","position":"Corporate Secretary"},{"name":"BI Jie","position":"Chief Business Officer"},{"name":"GENG Guo Zhu","position":"Other Senior Executives"},{"name":"CHEN Jing","position":"Other Senior Executives"},{"name":"SHU Yin Jiao","position":"Other Senior Executives"}]}}}